Telsey Advisory Group downgraded shares of Five Below (NASDAQ:FIVE – Free Report) from an outperform rating to a market perform rating in a report issued on Monday morning, MarketBeat Ratings reports. Telsey Advisory Group currently has $95.00 target price on the specialty retailer’s stock, down from their previous target price of $102.00. Telsey Advisory Group also issued estimates for Five Below’s Q4 2025 earnings at $3.27 EPS, FY2025 earnings at $4.59 EPS, Q1 2026 earnings at $0.50 EPS, Q2 2026 earnings at $0.61 EPS, Q3 2026 earnings at $0.20 EPS, Q4 2026 earnings at $3.60 EPS and FY2026 earnings at $4.91 EPS.
Other equities research analysts have also recently issued research reports about the company. The Goldman Sachs Group decreased their target price on Five Below from $124.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. KeyCorp lowered shares of Five Below from an “overweight” rating to a “sector weight” rating in a research note on Thursday, November 7th. Craig Hallum increased their target price on shares of Five Below from $102.00 to $125.00 and gave the stock a “buy” rating in a research note on Wednesday, October 2nd. UBS Group decreased their price target on shares of Five Below from $120.00 to $108.00 and set a “buy” rating for the company in a research note on Wednesday, August 21st. Finally, Mizuho reissued a “neutral” rating and set a $85.00 price objective on shares of Five Below in a research report on Thursday, October 3rd. Three research analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $106.05.
View Our Latest Report on Five Below
Five Below Stock Up 4.6 %
Five Below (NASDAQ:FIVE – Get Free Report) last issued its quarterly earnings results on Wednesday, August 28th. The specialty retailer reported $0.54 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.54. Five Below had a return on equity of 18.16% and a net margin of 7.57%. The firm had revenue of $830.07 million during the quarter, compared to the consensus estimate of $821.95 million. Sell-side analysts anticipate that Five Below will post 4.57 EPS for the current fiscal year.
Institutional Trading of Five Below
Several institutional investors and hedge funds have recently made changes to their positions in FIVE. Paladin Wealth LLC purchased a new position in Five Below during the third quarter worth about $26,000. Brooklyn Investment Group bought a new position in shares of Five Below in the third quarter valued at approximately $30,000. Partnership Wealth Management LLC increased its position in shares of Five Below by 2,000.0% during the second quarter. Partnership Wealth Management LLC now owns 315 shares of the specialty retailer’s stock valued at $34,000 after acquiring an additional 300 shares during the last quarter. LRI Investments LLC bought a new stake in Five Below during the first quarter worth $38,000. Finally, Wilmington Savings Fund Society FSB purchased a new position in Five Below in the third quarter worth $42,000.
Five Below Company Profile
Five Below, Inc operates as a specialty value retailer in the United States. The company offers range of accessories, which includes novelty socks, sunglasses, jewelry, scarves, gloves, hair accessories, athletic tops and bottoms, and t-shirts, as well as nail polish, lip gloss, fragrance, and branded cosmetics; and personalized living space products, such as lamps, posters, frames, fleece blankets, plush items, pillows, candles, incense, lighting, novelty décor, accent furniture, and related items, as well as provides storage options.
Featured Stories
- Five stocks we like better than Five Below
- How to Calculate Return on Investment (ROI)
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Where to Find Earnings Call Transcripts
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the Dogs of the Dow Strategy? Overview and Examples
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Five Below Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Five Below and related companies with MarketBeat.com's FREE daily email newsletter.